Tang Capital Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,631
Closed -$912K 79
2025
Q4
$912K Sell
34,631
-1,065,369
-97% -$23.2M 0.05% 71
2025
Q3
$18.8M Hold
1,100,000
0.72% 39
2025
Q2
$13.8M Hold
1,100,000
0.7% 40
2025
Q1
$13.1M Hold
1,100,000
0.72% 37
2024
Q4
$16.1M Hold
1,100,000
1.07% 24
2024
Q3
$13.8M Hold
1,100,000
0.99% 32
2024
Q2
$9.36M Hold
1,100,000
0.95% 36
2024
Q1
$11.6M Hold
1,100,000
1.2% 27
2023
Q4
$11.4M Hold
1,100,000
1.06% 26
2023
Q3
$6.97M Hold
1,100,000
0.98% 35
2023
Q2
$9.5M Hold
1,100,000
1.4% 24
2023
Q1
$9.94M Buy
1,100,000
+700,000
+175% +$6.1M 1.48% 23
2022
Q4
$3.14M Buy
+400,000
New +$2.81M 0.46% 51

Other funds holding ZYME

Tang Capital Management's ZYME Position: Q1 2026 in Review

Tang Capital Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 34,631 shares — an estimated $912K sold.

Tang Capital Management first reported a position in ZYME in Q4 2022 and held it in 13 quarters. The position peaked at $18.8M in Q3 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Tang Capital Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Tang Capital Management sold 34,631 Zymeworks shares in Q1 2026, an estimated $912K.
  • Tang Capital Management first reported a position in Zymeworks in Q4 2022 and held it in 13 quarters.
  • Tang Capital Management's Zymeworks position peaked at $18.8M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.